2021 annual financial data
Grace Therapeutics 2021 Operating margin
Grace Therapeutics 2021 operating margin with verified reported values.
Direct answer
Operating margin was -8,377.05%.
Operating income was -25,911,738 USD and net income was -31,054,946 USD.
Operating cash flow was -17,988,196 USD.
Get free Grace Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 309,318 USD
- Operating income
- -25,911,738 USD
- Net income
- -31,054,946 USD
- Operating cash flow
- -17,988,196 USD